13D/13G Filings - T. Rowe Price Associates, Inc.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...46, 47, 48, 49, 50, ...100, 101, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
2:34 pm
Sale
2021-12-31 13G GoHealth, Inc.
GOCO
T. Rowe Price Associates, Inc. 14,193
0.100%
-369,174decrease
(-96.30%)
Filing
History
2022-02-14
2:34 pm
Purchase
2021-12-31 13G Kymera Therapeutics, Inc.
KYMR
T. Rowe Price Associates, Inc. 3,550,528
6.900%
3,550,528increase
(New Position)
Filing
History
2022-02-14
2:34 pm
Purchase
2021-12-31 13G Opendoor Technologies Inc.
OPEN
T. Rowe Price Associates, Inc. 36,169,638
5.900%
36,169,638increase
(New Position)
Filing
History
2022-02-14
2:34 pm
Sale
2021-12-31 13G PROG Holdings, Inc.
PRG
T. Rowe Price Associates, Inc. 5,578,830
8.500%
-332,004decrease
(-5.62%)
Filing
History
2022-02-14
2:34 pm
Purchase
2021-12-31 13G Imago BioSciences, Inc.
IMGO
T. Rowe Price Associates, Inc. 2,241,917
6.600%
2,241,917increase
(New Position)
Filing
History
2022-02-14
2:34 pm
Purchase
2021-12-31 13G FIGS, Inc.
FIGS
T. Rowe Price Associates, Inc. 14,057,521
9.200%
14,057,521increase
(New Position)
Filing
History
2022-02-14
2:34 pm
Sale
2021-12-31 13G Asana, Inc.
ASAN
T. Rowe Price Associates, Inc. 35,270
0.000%
-4,511,852decrease
(-99.22%)
Filing
History
2022-02-14
2:34 pm
Purchase
2021-12-31 13G Tenaya Therapeutics, Inc.
TNYA
T. Rowe Price Associates, Inc. 2,993,503
7.200%
2,993,503increase
(New Position)
Filing
History
2022-02-14
2:34 pm
Purchase
2021-12-31 13G Eucrates Biomedical Acquisition Corp.
EUCRU
T. Rowe Price Associates, Inc. 730,864
5.400%
730,864increase
(New Position)
Filing
History
2022-02-14
2:34 pm
Purchase
2021-12-31 13G Immuneering Corporation
IMRX
T. Rowe Price Associates, Inc. 3,188,505
12.200%
151,523increase
(+4.99%)
Filing
History
2022-02-14
2:34 pm
Purchase
2021-12-31 13G Rapid Micro Biosystems, Inc.
RPID
T. Rowe Price Associates, Inc. 2,199,746
6.300%
2,199,746increase
(New Position)
Filing
History
2022-02-14
2:34 pm
Sale
2021-12-31 13G Equitable Holdings, Inc.
EQH
T. Rowe Price Associates, Inc. 45,033,655
11.100%
-11,167,346decrease
(-19.87%)
Filing
History
2022-02-14
2:34 pm
Sale
2021-12-31 13G U.S. Xpress Enterprises, Inc.
USX
T. Rowe Price Associates, Inc. 1,680,305
4.800%
-409,799decrease
(-19.61%)
Filing
History
2022-02-14
2:34 pm
Purchase
2021-12-31 13G Replimune Group, Inc.
REPL
T. Rowe Price Associates, Inc. 5,868,638
12.500%
799,188increase
(+15.76%)
Filing
History
2022-02-14
2:34 pm
Purchase
2021-12-31 13G Endava plc
DAVA
T. Rowe Price Associates, Inc. 4,210,823
10.900%
365,574increase
(+9.51%)
Filing
History
2022-02-14
2:34 pm
Purchase
2021-12-31 13G IGM Biosciences, Inc.
IGMS
T. Rowe Price Associates, Inc. 2,371,275
9.100%
1,042,491increase
(+78.45%)
Filing
History
2022-02-14
2:34 pm
Sale
2021-12-31 13G The Pennant Group, Inc.
PNTG
T. Rowe Price Associates, Inc. 4,069,175
14.200%
-193,174decrease
(-4.53%)
Filing
History
2022-02-14
2:34 pm
Purchase
2021-12-31 13G The Baldwin Insurance Group, Inc.
BWIN
T. Rowe Price Associates, Inc. 4,820,435
8.400%
2,409,858increase
(+99.97%)
Filing
History
2022-02-14
2:34 pm
Sale
2021-12-31 13G Match Group, Inc.
MTCH
T. Rowe Price Associates, Inc. 14,172,214
5.000%
-7,254,234decrease
(-33.86%)
Filing
History
2022-02-14
2:34 pm
Purchase
2021-12-31 13G Annexon, Inc.
ANNX
T. Rowe Price Associates, Inc. 2,876,667
7.400%
2,876,667increase
(New Position)
Filing
History
Goto Prev, 0, 1, ...46, 47, 48, 49, 50, ...100, 101, Next